(Q39534526)

12 September 2017

title

Is chloroquine obsolete in treatment of rheumatic disease? (English)

1 reference

12 September 2017

0 references

J. S. Marks

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85016

11 November 2022

B. J. Power

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A85016

11 November 2022

language of work or name

English

0 references

publication date

1 February 1979

1 reference

12 September 2017

17 February 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=85016

full work available at URL

11 November 2022

https://api.elsevier.com/content/article/PII:S0140673679929052?httpAccept=text/xml

1 reference

10.1016/S0140-6736(79)92905-2

DOI

https://api.crossref.org/works/10.1016/S0140-6736(79)92905-2

https://api.elsevier.com/content/article/PII:S0140673679929052?httpAccept=text/plain

11 November 2022

1 reference

10.1016/S0140-6736(79)92905-2

DOI

https://api.crossref.org/works/10.1016/S0140-6736(79)92905-2

11 November 2022

1 reference

12 September 2017

volume

1

1 reference

12 September 2017

issue

8112

1 reference

12 September 2017

page(s)

371-373

1 reference

Chloroquine in rheumatoid arthritis; a double blindfold trial of treatment for one year

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine diphosphate in rheumatoid arthritis. A controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

The ocular complications of chloroquine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Ocular abnormalities in patients treated with synthetic antimalarial drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Unusual ocular lesions in a case of systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine (Aralen)-induced retinal damage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

OCULAR LESIONS AFTER TREATMENT WITH CHLOROQUINE.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Ocular lesions in rheumatoid arthritis and related disorders with particular reference to retinopathy. A study of 741 patients treated with and without chloroquine drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Antimalarial therapy and early retinal changes in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine: ophthalmological safety, and clinical assessment in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine retinopathy in patients with rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Ophthalmological safety of chloroquine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine Retinopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Chloroquine retinopathy; a report of eight cases with ERG and dark-adaptation findings

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

Ocular toxicity of antimalarial drugs. Long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992905-2

7 January 2021

10.1016/S0140-6736(79)92905-2

Identifiers

DOI

1 reference

release_kuijdcv7njanxadxq7vvneis3a

12 September 2017

Fatcat ID

0 references

1 reference